Taming killer cells may halt diabetes progression
(2010) In Nature Immunology 11(2). p.111-112- Abstract
- Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1547226
- author
- Colucci, Francesco and Cilio, Corrado LU
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Nature Immunology
- volume
- 11
- issue
- 2
- pages
- 111 - 112
- publisher
- Nature Publishing Group
- external identifiers
-
- wos:000273730200006
- scopus:75649151690
- pmid:20084067
- ISSN
- 1529-2908
- DOI
- 10.1038/ni0210-111
- language
- English
- LU publication?
- yes
- id
- 7e20105b-8813-488c-9381-6c59c459c5e1 (old id 1547226)
- date added to LUP
- 2016-04-01 14:33:54
- date last changed
- 2022-01-28 01:19:22
@misc{7e20105b-8813-488c-9381-6c59c459c5e1,
abstract = {{Preclinical studies in mice suggest that the natural killer cell receptor NKp46 may be a new molecular target for delaying the progression of type 1 diabetes by interfering with unexpected natural killer cell-mediated recognition of pancreatic beta cells.}},
author = {{Colucci, Francesco and Cilio, Corrado}},
issn = {{1529-2908}},
language = {{eng}},
number = {{2}},
pages = {{111--112}},
publisher = {{Nature Publishing Group}},
series = {{Nature Immunology}},
title = {{Taming killer cells may halt diabetes progression}},
url = {{http://dx.doi.org/10.1038/ni0210-111}},
doi = {{10.1038/ni0210-111}},
volume = {{11}},
year = {{2010}},
}